About LEUKEMIA
Connecting you with India’s leading specialists in these medical fields
Leukemia is a cancer of the blood and bone marrow, where the body makes too many abnormal white blood cells.
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Pediatric and Adult Leukemia
- Bone Marrow Transplant (if needed)
CAR-T (Chimeric Antigen Receptor T-cell) Therapy is a cutting-edge immunotherapy where a patient’s own T-cells are modified in a lab to attack cancer cells. It is mainly used for blood cancers like leukemia and lymphoma.
- Highly personalized – uses the patient’s own immune cells.
- Effective for resistant cancers – especially relapsed blood cancers.
- Long-term remission – some patients experience years without relapse.
- Very expensive – due to complex genetic modification.
- Severe side effects – like cytokine release syndrome (CRS).
- Limited availability – only in select advanced centers.
- USD: $350,000 to $500,000
- Kenya Shillings (KES): Approx. KES 45,000,000 to 65,000,000
This includes T-cell collection, lab modification, hospitalization, and aftercare. May vary depending on cancer type and hospital.
A Bone Marrow Transplant (BMT) is a medical procedure where damaged or destroyed bone marrow is replaced with healthy stem cells. It is used to treat blood cancers (like leukemia, lymphoma), aplastic anemia, and certain genetic diseases.
- Potential cure for certain cancers and blood disorders.
- Restores healthy blood cell production.
- Can allow for high-dose chemotherapy/radiation by rescuing the bone marrow afterward.
- High risk of complications – e.g., infection, graft-versus-host disease (GVHD).
- Requires a close donor match – especially for allogeneic transplants.
- Intensive process – long hospital stay and strict post-care.
🔹 Autologous BMT (patient’s own cells)
- USD: $18,000 – $30,000
- KES: Approx. 2.4M – 4.0M
🔹 Allogeneic BMT (donor cells)
- USD: $28,000 – $45,000
- KES: Approx. 3.8M – 6.0M
Cost includes donor matching, harvesting, transplant, hospitalization, medications, and follow-up. Costs vary by hospital and complexity.
Targeted therapy is a cancer treatment that uses drugs to specifically target cancer cells without harming most normal cells. It works by blocking the growth and spread of cancer by interfering with specific molecules involved in tumor growth.
- More precise than chemotherapy – targets only cancer-related proteins.
- Fewer side effects compared to traditional chemo.
- Can be used alongside other treatments like chemo or radiation.
- Works only for cancers with specific genetic markers.
- Cancer may become resistant over time.
- High cost and may require continuous use.
(Costs depend on cancer type, drug used, and duration)
- Per cycle/month (common range):
- USD: $1,500 – $3,500
- KES: Approx. 200,000 – 470,000
- 6-month course (average):
- USD: $9,000 – $21,000
- KES: Approx. 1.2M – 2.8M
Note: Drugs like Herceptin, Imatinib, or Osimertinib may be used. Genetic testing may be required before starting.
Upload table as is from word document or anywhere
Upload table as is from word document or anywhere
Upload table as is from word document or anywhere
Upload table as is from word document or anywhere